Glenmark Pharma Q2 Results : Co posts Rs 355 crore net profit on robust sales (...)
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.
Site référencé: The Economic Times
The Economic Times
From fall to flight : 7 smallcap stocks stage a strong comeback in 2025
9/08/2025
Raksha Bandhan : Could a mutual fund SIP gift today secure your sibling’s future ?
9/08/2025
HDFC Bank, ICICI Bank poised for strong FY27 earnings, Says Motilal Oswal’s Khemka
9/08/2025
Mind Over Money : From F1 Tracks to Tennis Courts — How Sports Shape Ashish Singhal’s Entrepreneurial Mindset
9/08/2025
Cautious on IT, bullish on hospitals and consumption themes : Mayuresh Joshi
9/08/2025
Markets show maturity amid volatility ; technicals hint at profit booking ahead : Shivangi Sarda
9/08/2025
